HARVARD BIOSCIENCE INC
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
| Item 2. | Properties. |
|---|
Our facilities perform manufacturing, research and development, sales and marketing, and administration functions. As of December 31, 2023, we leased the following principal facilities:
| Approximate | |||
|---|---|---|---|
| Location | Description of Facility | Square Footage | Expiration |
| Holliston, Massachusetts | Manufacturing facility and corporate headquarters | 83,000 | 2024 |
| New Brighton, Minnesota | Manufacturing facility | 75,000 | 2030 |
| Reutlingen, Germany | Manufacturing facility | 23,000 | 2024 |
| Barcelona, Spain | Manufacturing facility | 16,000 | 2024 |
| March-Hugstetten, Germany | Manufacturing facility | 11,000 | 2024 |
We also lease facilities in Cambridge, England; Kista, Sweden; Beijing, China; and Shanghai, China. We believe our current facilities are adequate for our needs for the foreseeable future.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.